Manager, Health Economics & Payer Evidence (HEPE)

At AstraZeneca, we pride ourselves on crafting a collaborative culture that champions knowledge-sharing, ambitious thinking and innovation – ultimately providing employees with the opportunity to work across teams, functions and even the globe.

Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office is purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.

Are you motivated by bringing new, innovative medicines to patients in Canada? Do you want to make a difference in how your economic models and evidence translates to real-world, system-wide, clinical decision making in Canada and abroad?

Our Position : Manager, Health Economics & Payer Evidence

Reporting to the Director, Payer Evidence, Methods, & Access Affairs (PEMA), you will be accountable for unlocking the value of our medicines through the strategic design and delivery of economic models and payer evidence to HTA agencies and payers in Canada. Using your expertise in health economics and evidence generation, you will lead the creation of economic evidence plans, working with external clinical and payer experts, in Canada and abroad, as well as a diverse cross-functional team to execute and implement your strategies. This includes conducting external literature reviews, exploring public databases, or generating bespoke real-world evidence to support your health economic modelling. You will provide thought leadership to the Canadian health economic community through publications and presentations. This role will make a difference in the way healthcare is valued and improve the lives of Canadian patients through access to innovative medicines.

What you wil do in this role:

• Lead the development of high-quality economic dossiers of submissions to HTA reviewers within the public healthcare system and private insurers, ensuring accurate, strategic, and timely filings for assigned portfolio.
• You will work with Global colleagues in critically assessing the applicability of health economic models and comparative evidence (ITCs/NMAs/MAICs), leading adaptations to meet Canadian requirements.
• Identify payer evidence gaps and devise plans to demonstrate the value of our products, focusing on outcomes meaningful to payers and HTA decision-makers.
• With Medical Evidence, you work with external guides in creating real-world evidence (RWE), translating this evidence into economic value, and supporting publications to benefit the scientific community. You will attend and present this evidence at external conferences and meetings.
• You devise plans to demonstrate the value of our products to payers and HTA decision-makers, working with external experts, translating payer evidence into economic value, and supporting publications to benefit the scientific community. You will attend and present at external conferences and meetings.
• You will work with the Director PEMA, to understand, assess, and identify best HTA and health economic practices from other healthcare systems and developing plans on adapting these to the Canadian healthcare environment.
• With Market Access Strategy, you engage with external stakeholders to validate economic evaluation strategies and novel approaches. Through engagements, you will build a network of external stakeholders (economists, clinicians, academics).
• Act as the project owner when working with vendors on health economic related projects.

Basic Qualifications:

• A genuine interest in health economic evaluation methods, applications, and HTA.
• Advanced education in a numerate subject (e.g. health economics, epidemiology, biostatistics, healthcare forecasting, management science).
• 3+ years of pharmaceutical industry or health-related/HTA experience involving reimbursement or health policy, or similar agency/government experience.
• Practical experience with cost-effectiveness models, systematic reviews, network meta-analysis, survival/statistical analyses, budget impact models, with HTA submissions to CADTH and INESSS.
• A thorough understanding of payer evidence requirements (HRQoL studies, costing studies, SLRs, ITCs NMAs, retrospective database analyses, prospective physician or patient epidemiological studies) and applications of RWE.
• A strong understanding and interest of healthcare systems and reimbursement processes in Canada and abroad

Skills and Capabilities

• A high level of initiative, sense of urgency, and ability to lead multiple priorities of significant scope in a fast-paced environment
• Critical thinking to objectively appraise evidence with detailed, analytical skills in reviewing pharmacoeconomic submission materials
• Strategically agile with the ability to synthesize information from diverse sources to inform and formulate strategies and initiatives
• As the future oncology business rapidly changes, this role requires learning flexibility and working with ambiguity is necessary
• Demonstrated ability to work with cross functional and global teams with excellent communication and project management skills

Great People want to Work with us! Find out why:

• GTAA Top Employer Award for 9 years
• Learn about our culture
• Learn more about working with us in Canada
• View our YouTube channel

Are you interested in working at AZ, apply today!